Log in

NYSE:CTVACorteva Stock Price, Forecast & News

$27.02
+0.23 (+0.86 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$26.46
Now: $27.02
$27.40
50-Day Range
$22.77
MA: $26.49
$30.65
52-Week Range
$20.38
Now: $27.02
$32.78
Volume3.64 million shs
Average Volume4.90 million shs
Market Capitalization$20.22 billion
P/E RatioN/A
Dividend Yield1.94%
BetaN/A
Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.03 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural production - crops
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone302-485-3000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$13.85 billion
Cash Flow$5.45 per share
Book Value$32.81 per share

Profitability

Net Income$-959,000,000.00

Miscellaneous

EmployeesN/A
Market Cap$20.22 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive CTVA News and Ratings via Email

Sign-up to receive the latest news and ratings for CTVA and its competitors with MarketBeat's FREE daily newsletter.

Corteva (NYSE:CTVA) Frequently Asked Questions

How has Corteva's stock been impacted by COVID-19 (Coronavirus)?

Corteva's stock was trading at $25.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CTVA shares have increased by 8.1% and is now trading at $27.02. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Corteva?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There are currently 2 sell ratings, 9 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Corteva.

When is Corteva's next earnings date?

Corteva is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Corteva.

How were Corteva's earnings last quarter?

Corteva (NYSE:CTVA) posted its quarterly earnings data on Wednesday, May, 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.39 by $0.20. The firm earned $3.96 billion during the quarter, compared to analyst estimates of $3.56 billion. Corteva had a negative net margin of 5.91% and a positive return on equity of 5.09%. The business's revenue for the quarter was up 16.5% on a year-over-year basis. View Corteva's earnings history.

How often does Corteva pay dividends? What is the dividend yield for Corteva?

Corteva announced a quarterly dividend on Tuesday, April 28th. Stockholders of record on Friday, May 15th will be given a dividend of $0.13 per share on Monday, June 15th. This represents a $0.52 annualized dividend and a yield of 1.92%. The ex-dividend date is Thursday, May 14th. View Corteva's dividend history.

What price target have analysts set for CTVA?

22 equities research analysts have issued twelve-month price targets for Corteva's stock. Their forecasts range from $24.00 to $39.00. On average, they anticipate Corteva's stock price to reach $30.69 in the next twelve months. This suggests a possible upside of 13.6% from the stock's current price. View analysts' price targets for Corteva.

Has Corteva been receiving favorable news coverage?

Media headlines about CTVA stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Corteva earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Corteva.

Are investors shorting Corteva?

Corteva saw a decline in short interest in June. As of June 15th, there was short interest totaling 9,730,000 shares, a decline of 25.9% from the May 31st total of 13,130,000 shares. Based on an average daily volume of 5,060,000 shares, the days-to-cover ratio is presently 1.9 days. Currently, 1.3% of the company's stock are sold short. View Corteva's Current Options Chain.

Who are some of Corteva's key competitors?

What other stocks do shareholders of Corteva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Corteva investors own include Dow Chemical (DOW), Cisco Systems (CSCO), AT&T (T), CVS Health (CVS), Verizon Communications (VZ), E I Du Pont De Nemours And Co (DD), Home Depot (HD), Johnson & Johnson (JNJ), NVIDIA (NVDA) and Walt Disney (DIS).

What is Corteva's stock symbol?

Corteva trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTVA."

Who are Corteva's major shareholders?

Corteva's stock is owned by many different institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (0.02%) and Park National Corp OH (0.00%). Company insiders that own Corteva stock include Cornel B Fuerer, Gregory R Friedman, Gregory R Page, James C Jr Collins, Klaus A Engel and Timothy P Glenn. View institutional ownership trends for Corteva.

Which institutional investors are selling Corteva stock?

CTVA stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, and Park National Corp OH. View insider buying and selling activity for Corteva.

How do I buy shares of Corteva?

Shares of CTVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Corteva's stock price today?

One share of CTVA stock can currently be purchased for approximately $27.02.

How big of a company is Corteva?

Corteva has a market capitalization of $20.22 billion and generates $13.85 billion in revenue each year. The company earns $-959,000,000.00 in net income (profit) each year or $1.43 on an earnings per share basis.

What is Corteva's official website?

The official website for Corteva is www.corteva.com.

How can I contact Corteva?

Corteva's mailing address is 974 CENTRE ROAD, WILMINGTON DE, 19805. The company can be reached via phone at 302-485-3000.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.